logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
18/01/2026
Market news: Sequoia Capital will participate in a round of financing led by the Singapore government investment company and the American investment institution Coatue Capital, with each institution contributing $1.5 billion.
Latest
3 m ago
Jiangsu Provincial Meteorological Bureau initiates Level IV emergency response for major meteorological disasters.
4 m ago
NBC News: Trump holds private conversation with aides about Canada issue.
5 m ago
NBC News: Trump says Canada needs to increase defense spending.
7 m ago
According to AI Fast News, Huatai Securities released a research report on January 18th, giving a "buy" rating to Zhongsheng Pharmaceutical (002317.SZ). The reasons for the rating include: 1) The domestic commercialization cooperation of the long-acting GLP-1RAY1225 has been achieved, and continued attention to overseas equity authorization; 2) The listing of the innovative flu drug Arlovidine tablets, and expectations for gradual increase in sales volume. (Daily Economic News)
8 m ago
According to Every AI Express, Hua Jin Securities published a research report on January 18th, giving Shunluo Electronics (002138.SZ) a "buy" rating. The rating reasons mainly include: 1) Adapting to the development of AI data centers, developing a technology platform suitable for LPD/VPD/IVR and other xPU power supply modes; 2) Continuing to promote tantalum capacitor products and providing customer-matched product lines. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.